Both in Biotechnology
Vericel vs BioCryst Pharmaceuticals
Over the past year VCEL returned +27.7% and BCRX returned +9.5%; their daily moves had a correlation of 0.09.
VCEL +27.7% BCRX +9.5%Growth of $1, one year, split-adjusted
| Metric | VCEL | BCRX |
|---|---|---|
| Price | $40.61 | $8.27 |
| Market cap | $2.08B | $2.11B |
| Today | +0.92% | −2.36% |
| 1 month | −0.8% | −15.8% |
| 6 months | +32.9% | −12.5% |
| Year to date | +12.8% | +6.0% |
| 1 year | +34.3% | +8.4% |
| Revenue growth (YoY) | +22.5% | +33.6% |
| Gross margin | 72.8% | 98.2% |
| Net margin | 2.8% | 35.9% |
| P/E (TTM) | 85.9× | — |
| Price / sales | 6.8× | 2.2× |
| Net cash | $162.5M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 28.8% | 48.0% |
| Short % of float | 11.6% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).